Swiss Nordic Bio Zürich 30 March 2023
| Reference number | |
| Coordinator | Abilion Medical Systems AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | March 2023 - March 2023 |
| Status | Completed |
| Venture | 2023-00007-en |
Important results from the project
The trip has created new and deepened existing contacts with investors in the DACH area.
Expected long term effects
The result so far is that investment proposals have been sent out to a number of new contacts. Hopefully, in the long run, it can lead to investments.
Approach and implementation
All planned meetings were held and have been followed up with additional information and investment proposals being sent out.